Based on the findings of a new study led by the Translational Genomics Research Institute (TGen), part of City of Hope, a coast-to-coast clinical trial is planned that, if successful, could lead to FDA approval of the first ...
May 3, 2022
0
70
Until recently, babies and children with spinal muscular atrophy (SMA) lacked any type of treatment capable of stopping the neuromuscular disease from progressing. In SMA, damaged motor neurons in the spinal cord fail to ...
Aug 20, 2021
0
229
The mRNA vaccines for COVID-19, made by Pfizer/BioNTech and Moderna, are among the most powerful vaccines the world has ever seen. According to clinical trial data, they are more than 94% effective at preventing symptomatic ...
Jul 14, 2021
1
582
Researchers say they've developed a low-cost swab test that can diagnose COVID-19 infections in about 45 minutes.
Apr 16, 2020
1
610
(Medical Xpress)—Researchers from the University of Toronto's Department of Laboratory Medicine and Pathobiology (LMP) have discovered a new way to effectively target a previously difficult-to-treat form of childhood brain ...
Feb 20, 2014
0
0
Over the past few decades, scientists have developed many devices that can reopen clogged arteries, including angioplasty balloons and metallic stents. While generally effective, each of these treatments has drawbacks, including ...
May 21, 2013
0
0
Nisin, a common food preservative, may slow or stop squamous cell head and neck cancers, a University of Michigan study found.
Oct 31, 2012
0
0
A new study by researchers at Weill Cornell Medical College shows combining two already-FDA approved drugs may offer a new and potent punch against diseases in which blood vessel growth is abnormal—such as cancer, diabetic ...
Sep 10, 2012
0
0
New research questions the effectiveness of the U.S. Food and Drug Administration's accelerated drug approval program after finding that many cancer drugs remain unproven five years later.
Apr 8, 2024
0
2
Drug approvals in the United States between 2010–2019 were aligned with the US, but not global, burden of disease and the increasing number of expedited drug approvals could make the gap worse according to a study in the ...
Mar 12, 2024
0
0
